GIUIX | PMBJX | GIUIX / PMBJX | |
Total Expense Ratio | 1.26 | 0.78 | 162% |
Annual Report Gross Expense Ratio | 1.26 | 0.78 | 162% |
Fund Existence | 14 years | 25 years | - |
Gain YTD | 2.396 | 2.303 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 1000 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 70.8M | 31.9B | 0% |
Annual Yield % from dividends | 2.70 | 0.06 | 4,795% |
Returns for 1 year | 1.04 | -3.03 | -34% |
Returns for 3 years | 13.35 | 48.67 | 27% |
Returns for 5 years | -17.53 | 34.98 | -50% |
Returns for 10 years | -3.06 | 98.61 | -3% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 48.20 | 0.19 | +0.40% |
SPDR® S&P Pharmaceuticals ETF | |||
DFUV | 44.24 | 0.13 | +0.29% |
Dimensional US Marketwide Value ETF | |||
TXS | 36.05 | 0.03 | +0.08% |
Texas Capital Texas Equity Index ETF | |||
LFAI | 155.51 | N/A | N/A |
LifeX 2050 Longevity Income ETF | |||
ISHG | 75.86 | -0.06 | -0.08% |
iShares 1-3 Year International TrsBd ETF |